000130147 001__ 130147
000130147 005__ 20241125101153.0
000130147 0247_ $$2doi$$a10.37201/req/019.2023
000130147 0248_ $$2sideral$$a136469
000130147 037__ $$aART-2023-136469
000130147 041__ $$aspa
000130147 100__ $$aHerrero, Tina
000130147 245__ $$aAnalysis of the incidence and epidemiology of non-tuberculous mycobacterial infections in the health area III of Aragón
000130147 260__ $$c2023
000130147 5060_ $$aAccess copy available to the general public$$fUnrestricted
000130147 5203_ $$aObjectives. The main objective of our investigation was to know the incidence and epidemiology of non-tuberculous mycobacteria (NTM) in our area and the prevalence of comorbidities in patients with MNT infection. As secondary objectives, we studied the distribution by species of MNT, the forms of disease and the type of sample used for its diagnosis. Material and methods. A retrospective study was carried out in which all the isolates of mycobacteria carried out by the microbiology laboratory of the Hospital Clínico Universitario Lozano Blesa of Zaragoza during the period between January 1, 2011 and December 31, 2018 were included. Results. A total of 533 mycobacteria were isolated, of which 295 (55.35%) were tuberculosis (MTB) and 238 (44.65%) were MNT. Of the whole MNT isolates, only 15.54% were considered clinically significant. Twenty-one species were identified being the most frequent: M. gordonae (26.89%), M. fortuitum (19.75%) and M. avium (16.39%). 32.72% of the MNT isolates were found in people over 70 years of age. Conclusions. We can confirm that the reported number of MNT isolates in our area is higher than in previous periods. MNT infection is more common in men and those older than 70 years. The epidemiology, especially the risk factors, of MNT disease is changing.
000130147 540__ $$9info:eu-repo/semantics/openAccess$$aby-nc$$uhttp://creativecommons.org/licenses/by-nc/3.0/es/
000130147 590__ $$a1.9$$b2023
000130147 592__ $$a0.399$$b2023
000130147 591__ $$aPHARMACOLOGY & PHARMACY$$b231 / 354 = 0.653$$c2023$$dQ3$$eT2
000130147 593__ $$aMedicine (miscellaneous)$$c2023$$dQ3
000130147 591__ $$aMICROBIOLOGY$$b130 / 161 = 0.807$$c2023$$dQ4$$eT3
000130147 593__ $$aPharmacology$$c2023$$dQ3
000130147 593__ $$aMicrobiology (medical)$$c2023$$dQ3
000130147 594__ $$a2.9$$b2023
000130147 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/publishedVersion
000130147 700__ $$0(orcid)0000-0003-1436-4334$$aSanjoaquin, Maria Isabel$$uUniversidad de Zaragoza
000130147 700__ $$0(orcid)0000-0001-8471-3224$$aLafuente, Miguel$$uUniversidad de Zaragoza
000130147 700__ $$aCabrera, Luisa Margarita
000130147 700__ $$aBetrán, María
000130147 700__ $$aCamón, Ana Maria
000130147 7102_ $$12007$$2265$$aUniversidad de Zaragoza$$bDpto. Métodos Estadísticos$$cÁrea Estadís. Investig. Opera.
000130147 7102_ $$11007$$2610$$aUniversidad de Zaragoza$$bDpto. Medicina, Psiqu. y Derm.$$cArea Medicina
000130147 773__ $$g36, 5 (2023), 492-497$$pRev. esp. quimioter.$$tRevista española de quimioterapia$$x0214-3429
000130147 8564_ $$s301508$$uhttps://zaguan.unizar.es/record/130147/files/texto_completo.pdf$$yVersión publicada
000130147 8564_ $$s2982355$$uhttps://zaguan.unizar.es/record/130147/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada
000130147 909CO $$ooai:zaguan.unizar.es:130147$$particulos$$pdriver
000130147 951__ $$a2024-11-22-12:08:05
000130147 980__ $$aARTICLE